Can a smartphone app help beat TB and HIV together?
NCT ID NCT04298905
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a smartphone app and a tablet dashboard for community health workers to support people with both tuberculosis (TB) and HIV in South Africa. The app helps patients stay on track with their medications, while the dashboard alerts health workers if someone needs extra help. The goal is to improve treatment success and reduce deaths. About 62 adults with active TB and HIV are taking part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
smartphone app and community health worker dashboard
What this could lead to
If successful, this approach could improve treatment success rates for people with both TB and HIV in low-resource settings.
What could go wrong
This is a small, early-stage study with only 62 participants, so results may not apply broadly. The technology relies on consistent smartphone use and data connectivity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kelly Lowensen
Baltimore, Maryland, 21224-3750, United States